Developer of prescription products intended to serve the needs of the acute-care hospital setting. The company's products support the life of cancer patients, offer short-term treatment of hypertension and management of various AMI related conditions, enabling patients to get access to preferred treatment at a cost effective manner.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Merger/Acquisition | 27-Jun-2012 | $150M | 00000 | 00000 | Completed | Generating Revenue |
4. Later Stage VC (Series D) | 10-Mar-2008 | 00000 | 00000 | Completed | Startup | |
3. Later Stage VC (Series C) | 22-Aug-2007 | 000.00 | 000.00 | Completed | Startup | |
2. Early Stage VC (Series B) | 15-Nov-2006 | $7.33M | $7.33M | Completed | Startup | |
1. Early Stage VC (Series A) | 27-Jun-2006 | Completed | Startup |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Commerce Health Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
ESP Equity Partners | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Garden State Life Sciences Venture Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
LLR Partners | PE/Buyout | Minority | 000 0000 | 000000 0 | |
MPM Capital | Venture Capital | Minority | 000 0000 | 000000 0 |